A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development

← catalyst calendar

NCT06055725 · readout in 468 d

Sponsored by Ipsen (industry) · IPN.PA — their whole pipeline →.

Phase

—

Status

Active, not recruiting

Study type

Observational

Enrollment

1,058estimated

Sites

Countries

France, Germany, Italy +4

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis

Date

Filed

Basis

What it is

Start

2023-11-01

actual

When the study began enrolling

Primary completion

2027-11-30

estimated

The date the last participant is measured for the primary outcome — the readout window

Study completion

2027-11-30

estimated

The whole study's end, after follow-up

First posted

2023-09-28

actual

When this record first appeared on the registry

Results posted

—

When the sponsor posted results to the registry

Record updated

2026-07-08

actual

The sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

Spasticity as Sequela of Stroke

Primary outcome

what the primary-completion date above is the date OF

Percentage of participants at the Clinical Confirmation Visit (CCV) who have problematic spasticity and who the investigator considers would benefit from pharmacological therapy

measured At the Clinical Confirmation Visit (CCV) up to maximum 18 months

Publications

PMID 39819949 — linked by the registry

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · IPN.PA's whole pipeline · Catalyst calendar · Every registered study · What changed